Gut Liver. 2015 May 23;9(3):267-317. doi: 10.5009/gnl14460.
The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC.
肝细胞癌(HCC)管理指南最初由韩国肝癌研究组和韩国国立癌症中心于2003年制定,并于2009年进行了修订。从那时起,韩国和其他国家开展了许多关于HCC的研究。特别是,针对亚洲人特征,尤其是韩国人的诊断、分期和治疗积累了大量知识,促使人们提出新的策略。因此,本文提出的新指南是在最新证据和专家意见的基础上制定的。本指南的主要目标是疑似或新诊断为HCC的患者。本指南为新诊断为HCC的患者的初始治疗提供建议。